Polymeric nanoparticles enable reversing macrophage in tumor microenvironment for immunotherapy

Biomaterials

Volumn 112, Issue , 2017, Pages 153-163

  Wang, Yi ^a,b   Lin, Yao Xin ^a,b   Qiao, Sheng Lin ^a,b   An, Hong Wei ^a,b   Ma, Yang ^a,b   Qiao, Zeng Ying ^a   Rajapaksha, R P Yeshan J ^a,b   Wang, Hao ^a,b  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Cancer; Immunotherapy; Macrophage; Nanoparticles; Self assembly

Indexed keywords

DISEASES; MACROPHAGES; NANOPARTICLES; SELF ASSEMBLY; SYNTHESIS (CHEMICAL);

CANCER; CANCER IMMUNOTHERAPY; IMMUNOTHERAPY; POLYMERIC NANOPARTICLES; RESPONSIVE MATERIALS; SYSTEMIC ADMINISTRATION; TUMOR ASSOCIATED MACROPHAGES; TUMOR MICROENVIRONMENT;

TUMORS;

COPOLYMER; INTERLEUKIN 12; NANOPARTICLE; NANOCAPSULE; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DRUG CYTOTOXICITY; FEMALE; IMMUNOMODULATION; IN VIVO STUDY; MELANOMA B16; MELANOMA CELL LINE; MOUSE; NANOENCAPSULATION; NANOFABRICATION; NONHUMAN; PH; POLYMERIZATION; PRIORITY JOURNAL; RAW 264.7 CELL LINE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ADMINISTRATION AND DOSAGE; ANIMAL; C57BL MOUSE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; EXPERIMENTAL NEOPLASM; IMMUNOLOGY; MACROPHAGE; NUCLEAR REPROGRAMMING; PATHOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; CELL LINE, TUMOR; CELLULAR REPROGRAMMING; DELAYED-ACTION PREPARATIONS; FEMALE; INTERLEUKIN-12; MACROPHAGES; MICE; MICE, INBRED C57BL; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; POLYMERS; TUMOR MICROENVIRONMENT;

EID: 84991785915     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.09.034     Document Type: Article

References (52)

1. [1] Busse, W.W., Lemanske, R.F., Advances in immunology – asthma. N. Engl. J. Med. 344 (2001), 350–362.
2. [2] Dougan, M., Dranoff, G., Immune therapy for Cancer. Annu. Rev. Immunol. 27 (2009), 83–117.
3. [3] Mahoney, K.M., Rennert, P.D., Freeman, G.J., Combination cancer immunotherapy and new immunomodulatory targets. Nat. Rev. Drug Discov. 14 (2015), 561–584.
4. [4] Mellman, I., Coukos, G., Dranoff, G., Cancer immunotherapy comes of age. Nature 480 (2011), 480–489.
5. [5] Zitvogel, L., Apetoh, L., Ghiringhelli, F., Kroemer, G., Immunological aspects of cancer chemotherapy. Nat. Rev. Immunol. 8 (2008), 59–73.
6. [6] Chang, H.-N., Liu, B.-Y., Qi, Y.-K., Zhou, Y., Chen, Y.-P., Pan, K.-M., et al. Blocking of the PD-1/PD-L1 interaction by a D-peptide antagonist for cancer immunotherapy. Angew. Chem. Int Ed. 54 (2015), 11760–11764.
7. [7] Wang, C., Ye, Y., Hochu, G.M., Sadeghifar, H., Gu, Z., Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody. Nano Lett. 16 (2016), 2334–2340.
8. [8] Wang, C., Xu, L., Liang, C., Xiang, J., Peng, R., Liu, Z., Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis. Adv. Mater 26 (2014), 8154–8162.
9. [9] Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.T., et al. Immunobiology of dendritic cells. Annu. Rev. Immunol., 18, 2000 767-+.
10. [10] Black, M., Trent, A., Kostenko, Y., Lee, J.S., Olive, C., Tirrell, M., Self-assembled peptide amphiphile micelles containing a cytotoxic t-cell epitope promote a protective immune response in vivo. Adv. Mater 24 (2012), 3845–3849.
11. [11] Hamdy, S., Haddadi, A., Hung, R.W., Lavasanifar, A., Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations. Adv. Drug Deliv. Rev. 63 (2011), 943–955.
12. [12] Singh, A., Peppas, N.A., Hydrogels and scaffolds for immunomodulation. Adv. Mater 26 (2014), 6530–6541.
13. [13] Wen, Y., Liu, W., Bagia, C., Zhang, S., Bai, M., Janjic, J.M., et al. Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells. Acta Biomater. 10 (2014), 4759–4767.
14. [14] Wang, X., Sun, C., Li, P., Wu, T., Zhou, H., Yang, D., et al. Vaccine engineering with dual-functional mineral shell: a promising strategy to overcome preexisting immunity. Adv. Mater 28 (2016), 694–700.
15. [15] Moon, J.J., Huang, B., Irvine, D.J., Engineering nano- and microparticles to tune immunity. Adv. Mater 24 (2012), 3724–3746.
16. [16] Wen, Y., Collier, J.H., Supramolecular peptide vaccines: tuning adaptive immunity. Curr. Opin. Immunol. 35 (2015), 73–79.
17. [17] Solbrig, C.M., Saucier-Sawyer, J.K., Cody, V., Saltzman, W.M., Hanlon, D.J., Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells. Mol. Pharm. 4 (2007), 47–57.
18. [18] Perica, K., Tu, A., Richter, A., Bieler, J.G., Edidin, M., Schneck, J.P., Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity. Acs Nano 8 (2014), 2252–2260.
19. [19] Lin, W.-W., Karin, M., A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest 117 (2007), 1175–1183.
20. [20] Allavena, P., Sica, A., Garlanda, C., Mantovani, A., The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 222 (2008), 155–161.
21. [21] Liu, Y., Cao, X., The origin and function of tumor-associated macrophages. Cell Mol. Immunol. 12 (2015), 1–4.
22. [22] Martinez, F.O., Sica, A., Mantovani, A., Locati, M., Macrophage activation and polarization. Front. Biosci. 13 (2008), 453–461.
23. [23] Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M.G., et al. Macrophage polarization in tumour progression. Semin. Cancer Biol. 18 (2008), 349–355.
24. [24] Wynn, T.A., Chawla, A., Pollard, J.W., Macrophage biology in development, homeostasis and disease. Nature 496 (2013), 445–455.
25. [25] Lin, M., Zhang, Y., Chen, G., Jiang, M., Supramolecular glyco-nanoparticles toward immunological applications. Small 11 (2015), 6065–6070.
26. [26] Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.-K.L., Flavell, R.A., Transforming growth factor-beta regulation of immune responses. Nat. Rev. Immunol., 2006, 99–146.
27. [27] Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8 (2008), 958–969.
28. [28] Nastala, C.L., Edington, H.D., McKinney, T.G., Tahara, H., Nalesnik, M.A., Brunda, M.J., et al. Recombinant IL-12 administration induces tumor-regression in association with IFN-gamma production. J. Immunol. 153 (1994), 1697–1706.
29. [29] Trinchieri, G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3 (2003), 133–146.
30. [30] Watkins, S.K., Egilmez, N.K., Suttles, J., Stout, R.D., IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J. Immunol. 178 (2007), 1357–1362.
31. [31] Gu, L., Ruff, L.E., Qin, Z., Corr, M., Hedrick, S.M., Sailor, M.J., Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody. Adv. Mater 24 (2012), 3981–3987.
32. [32] Liu, Y., Li, L.-L., Qi, G.-B., Chen, X.-G., Wang, H., Dynamic disordering of liposomal cocktails and the spatio-temporal favorable release of cargoes to circumvent drug resistance. Biomaterials 35 (2014), 3406–3415.
33. [33] Liu, Z., Robinson, J.T., Sun, X., Dai, H., PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130 (2008), 10876–10877.
34. [34] Lin, Y.-X., Gao, Y.-J., Wang, Y., Qiao, Z.-Y., Fan, G., Qiao, S.-L., et al. pH-sensitive polymeric nanoparticles with gold(I) compound payloads synergistically induce cancer cell death through modulation of autophagy. Mol. Pharm. 12 (2015), 2869–2878.
35. [35] Smith, D., Holley, A.C., McCormick, C.L., RAFT-synthesized copolymers and conjugates designed for therapeutic delivery of iRNA. Polym. Chem. 2 (2011), 1428–1441.
36. [36] Lynn, D.M., Langer, R., Degradable poly(beta-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J. Am. Chem. Soc. 122 (2000), 10761–10768.
37. [37] Lynn, D.M., Amiji, M.M., Langer, R., pH-responsive polymer microspheres: rapid release of encapsulated material within the range of intracellular pH. Angew. Chem. Int Ed. 40 (2001), 1707–1710.
38. [38] Qiao, Z.-Y., Hou, C.-Y., Zhang, D., Liu, Y., Lin, Y.-X., An, H.-W., et al. Self-assembly of cytotoxic peptide conjugated poly(beta-amino ester)s for synergistic cancer chemotherapy. J. Mater Chem. B 3 (2015), 2943–2953.
39. [39] Wang, Y., Lin, Y.-X., Qiao, Z.-Y., An, H.-W., Qiao, S.-L., Wang, L., et al. Self-assembled autophagy-inducing polymeric nanoparticles for breast cancer interference in-vivo. Adv. Mater 27 (2015), 2627–2634.
40. [40] Steenblock, E.R., Fahmy, T.M., A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells. Mol. Ther. 16 (2008), 765–772.
41. [41] Lin, Y.-X., Wang, Y., Qiao, S.-L., An, H.-W., Zhang, R.-X., Qiao, Z.-Y., et al. pH-Sensitive polymeric nanoparticles modulate autophagic effect via lysosome impairment. Small, 12, 2016, 2921.
42. [42] Misson, P., van den Brule, S., Barbarin, V., Lison, D., Huaux, F., Markers of macrophage differentiation in experimental silicosis. J. Leukoc. Biol. 76 (2004), 926–932.
43. [43] An, G., Wang, H., Tang, R., Yago, T., McDaniel, J.M., McGee, S., et al. P-selectin glycoprotein ligand-1 is highly expressed on Ly-6C(hi) monocytes and a major determinant for Ly-6C(hi) monocyte recruitment to sites of atherosclerosis in mice. Circulation 117 (2008), 3227–3237.
44. [44] Brunda, M.J., Luistro, L., Warrier, R.R., Wright, R.B., Hubbard, B.R., Murphy, M., et al. Antitumor and antimetastastic activity of interleukin-12 against murine tumors. J. Exp. Med. 178 (1993), 1223–1230.
45. [45] Huang, Z., Yang, Y., Jiang, Y., Shao, J., Sun, X., Chen, J., et al. Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers. Biomaterials 34 (2013), 746–755.
46. [46] Xu, M., Liu, M., Du, X., Li, S., Li, H., Li, X., et al. Intratumoral delivery of il-21 overcomes Anti-Her2/Neu resistance through shifting tumor-associated macrophages from M2 to M1 phenotype. J. Immunol. 194 (2015), 4997–5006.
47. [47] Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25 (2001), 402–408.
48. [48] Chung-Ho, L., Youn-Jeong, K., Je-Hee, J., Jin-Woo, P., Modulating macrophage polarization with divalent cations in nanostructured titanium implant surfaces. Nanotechnology, 27, 2016, 085101.
49. [49] Qiao, Z.-Y., Qiao, S.-L., Fan, G., Fan, Y.-S., Chen, Y., Wang, H., One-pot synthesis of pH-sensitive poly(RGD-co-beta-amino ester)s for targeted intracellular drug delivery. Polym. Chem. 5 (2014), 844–853.
50. [50] Qiao, Z.-Y., Lin, Y.-X., Lai, W.-J., Hou, C.-Y., Wang, Y., Qiao, S.-L., et al. A General strategy for facile synthesis and in situ screening of self-assembled polymer-peptide nanomaterials. Adv. Mater 28 (2016), 1859–1867.
51. [51] Menon, A.G., Fleuren, G.J., Alphenaar, E.A., Jonges, L.E., van Rhijn, C.M.J., Ensink, N.G., et al. A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer. Cancer Immunol. Immunother. 52 (2003), 121–126.
52. [52] Motz, G.T., Santoro, S.P., Wang, L.-P., Garrabrant, T., Lastra, R.R., Hagemann, I.S., et al. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nat. Med. 20 (2014), 607–615.